Anti-Von Willebrand Factor antibody [EPR2992(N)]
- RabMAb
- Recombinant
- What is this?
5
(1 Review)
|
(2 Publications)
Rabbit Recombinant Monoclonal Von Willebrand Factor antibody. Suitable for IP, WB and reacts with Human samples. Cited in 2 publications.
View Alternative Names
F8VWF, VWF, von Willebrand factor, vWF
- IP
Supplier Data
Immunoprecipitation - Anti-Von Willebrand Factor antibody [EPR2992(N)] (AB181871)
Western blot analysis on immunoprecipitation pellet from Human plasma, labeling Von Willebrand Factor immunoprecipitated using ab181871 at 1/70 dilution and HRP-conjugated anti-rabbit IgG preferentially detecting the non-reduced form of rabbit IgG.
All lanes:
Immunoprecipitation - Anti-Von Willebrand Factor antibody [EPR2992(N)] (ab181871)
Predicted band size: 309 kDa
false
- WB
Supplier Data
Western blot - Anti-Von Willebrand Factor antibody [EPR2992(N)] (AB181871)
All lanes:
Western blot - Anti-Von Willebrand Factor antibody [EPR2992(N)] (ab181871) at 1/2000 dilution
Lane 1:
Human plasma lysate at 20 µg
Lane 2:
Human serum lysate at 20 µg
Lane 3:
HepG2 cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 309 kDa
Observed band size: 309 kDa
false
Related conjugates and formulations (1)
-
Anti-Von Willebrand Factor antibody [EPR2992(N)] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Discover oncology 15:333 PubMed39095628
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in neurology 11:549624 PubMed33117257
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com